Phase II study of oral S-1 with irinotecan and bevacizumab...

Investigational New Drugs 2012 / 08 Vol. 30; Iss. 4

Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer

Yasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, Yasushi Ichikawa, Ayumu Goto, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Pages:
7
DOI:
10.1007/s10637-011-9743-0
Date:
August, 2012
File:
PDF, 160 KB
english, 2012
Conversion to is in progress
Conversion to is failed